Fred Alger Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.01M | Sell |
35,942
-12,182
| -25% | -$3.03M | 0.04% | 176 |
|
|
2025
Q4 | $13.2M | Buy |
48,124
+28,390
| +144% | +$7.77M | 0.05% | 151 |
|
|
2025
Q3 | $5.18M | Buy |
19,734
+4,062
| +26% | +$987K | 0.02% | 237 |
|
|
2025
Q2 | $3.43M | Sell |
15,672
-394
| -2% | -$84.2K | 0.02% | 278 |
|
|
2025
Q1 | $3.6M | Sell |
16,066
-2,556
| -14% | -$704K | 0.02% | 256 |
|
|
2024
Q4 | $6.1M | Buy |
18,622
+4,528
| +32% | +$1.42M | 0.03% | 222 |
|
|
2024
Q3 | $4.23M | Sell |
14,094
-524
| -4% | -$160K | 0.02% | 256 |
|
|
2024
Q2 | $4.82M | Sell |
14,618
-37,150
| -72% | -$13.1M | 0.02% | 250 |
|
|
2024
Q1 | $20.5M | Buy |
51,768
+7,580
| +17% | +$2.8M | 0.1% | 146 |
|
|
2023
Q4 | $15.6M | Sell |
44,188
-54,613
| -55% | -$19.3M | 0.08% | 156 |
|
|
2023
Q3 | $37.1M | Buy |
98,801
+761
| +0.8% | +$294K | 0.21% | 103 |
|
|
2023
Q2 | $37.5M | Buy |
98,040
+28,884
| +42% | +$10.3M | 0.19% | 124 |
|
|
2023
Q1 | $24M | Buy |
69,156
+53,583
| +344% | +$15.7M | 0.13% | 154 |
|
|
2022
Q4 | $3.67M | Sell |
15,573
-11,143
| -42% | -$2.64M | 0.02% | 287 |
|
|
2022
Q3 | $6.57M | Buy |
26,716
+9,378
| +54% | +$2.86M | 0.03% | 234 |
|
|
2022
Q2 | $5.24M | Buy |
17,338
+13,829
| +394% | +$4.5M | 0.02% | 262 |
|
|
2022
Q1 | $1.44M | Sell |
3,509
-22,527
| -87% | -$8.82M | ﹤0.01% | 359 |
|
|
2021
Q4 | $12.2M | Buy |
26,036
+16,875
| +184% | +$7.26M | 0.03% | 231 |
|
|
2021
Q3 | $3.89M | Hold |
9,161
| – | – | 0.01% | 304 |
|
|
2021
Q2 | $3.29M | Sell |
9,161
-604
| -6% | -$200K | 0.01% | 325 |
|
|
2021
Q1 | $2.75M | Sell |
9,765
-343
| -3% | -$98.2K | 0.01% | 330 |
|
|
2020
Q4 | $2.86M | Sell |
10,108
-6
| -0.1% | -$1.68K | 0.01% | 311 |
|
|
2020
Q3 | $2.78M | Buy |
10,114
+3,114
| +44% | +$824K | 0.01% | 282 |
|
|
2020
Q2 | $1.59M | Buy |
7,000
+6,884
| +5,934% | +$1.35M | 0.01% | 321 |
|
|
2020
Q1 | $18K | Hold |
116
| – | – | ﹤0.01% | 444 |
|
|
2019
Q4 | $17K | Buy |
+116
| New | +$16.9K | ﹤0.01% | 459 |
|
|
2019
Q1 | – | Sell |
-119
| Closed | -$12K | – | 572 |
|
|
2018
Q4 | $12K | Hold |
119
| – | – | ﹤0.01% | 477 |
|
|
2018
Q3 | $15K | Buy |
+119
| New | +$13.3K | ﹤0.01% | 486 |
|
|
2017
Q4 | – | Sell |
-9,000
| Closed | -$866K | – | 596 |
|
|
2017
Q3 | $866K | Sell |
9,000
-4,000
| -31% | -$362K | ﹤0.01% | 331 |
|
|
2017
Q2 | $1.23M | Buy |
13,000
+6,000
| +86% | +$552K | 0.01% | 322 |
|
|
2017
Q1 | $571K | Sell |
7,000
-1,250
| -15% | -$105K | ﹤0.01% | 355 |
|
|
2016
Q4 | $700K | Buy |
8,250
+250
| +3% | +$19.7K | ﹤0.01% | 312 |
|
|
2016
Q3 | $596K | Sell |
8,000
-4,000
| -33% | -$318K | ﹤0.01% | 344 |
|
|
2016
Q2 | $911K | Buy |
12,000
+1,900
| +19% | +$138K | ﹤0.01% | 338 |
|
|
2016
Q1 | $700K | Buy |
+10,100
| New | +$608K | ﹤0.01% | 397 |
|
Other funds holding WST
VCM
VPM
GIM
Fred Alger Management's WST Position: Q1 2026 in Review
Fred Alger Management reduced its West Pharmaceutical (WST) stake by 25% in Q1 2026, selling an estimated $3.03M and leaving 35,942 shares worth $9.01M. The position accounts for 0.04% of the portfolio, ranked #176.
Fred Alger Management first reported a position in WST in Q1 2016 and has held it in 35 quarters since. The position peaked at $37.5M in Q2 2023. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Fred Alger Management held 35,942 shares of West Pharmaceutical worth $9.01M as of Q1 2026.
- Fred Alger Management sold 12,182 West Pharmaceutical shares in Q1 2026, an estimated $3.03M.
- West Pharmaceutical made up 0.04% of Fred Alger Management's portfolio in Q1 2026, its #176 holding.
- Fred Alger Management first reported a position in West Pharmaceutical in Q1 2016 and has held it in 35 quarters since.
- Fred Alger Management's West Pharmaceutical position peaked at $37.5M in Q2 2023.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.